Interestingly, agents that stimulate autophagy flux activation such as rapamycin have been proven to rescue tau pathology/cognitive impairment in experimental Alzheimer’s disease [9,12]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.